Levomoramide is the inactive isomer of the opioid analgesic dextromoramide, invented by the chemist Paul Janssen in 1956. Unlike dextromoramide, which is a potent analgesic with high abuse potential, levomoramide is virtually without activity.[2][3]
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
KEGG |
|
ECHA InfoCard | 100.024.658 |
Chemical and physical data | |
Formula | C25H32N2O2 |
Molar mass | 392.543 g·mol−1 |
3D model (JSmol) |
|
| |
| |
(what is this?) (verify) |
"Resolution reveals that the analgetic activity in this case resides almost entirely in the (+) isomer."[4]
"In the α-CH3 series, one of the optical isomers of each enantiomorphic pair is about twice as active as the racemic mixture; the other isomer is devoid of significant analgesic activity."[5]
However, despite being inactive, levomoramide is scheduled by UN Single Convention on Narcotic Drugs.